Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we ...

NeighborHealth, Massachusetts’ largest community-based primary care health system, has been recognized by the U.S. Department of Health and Human Services’ (HHS) Health Resources and Services ...

In his first term, President Donald Trump launched a bold and successful initiative against HIV. This time around, the ...

The Trump administration plans to make cuts to similar HIV prevention programs run by HHS for cost savings, an administration ...

The Department of Health and Human Services (HHS) has filed for summary judgment in its favor regarding lawsuits brought by ...

HHS has filed a legal brief urging a federal judge to dismiss lawsuits brought by pharmaceutical companies challenging the agency’s stance on 340B rebate models. Here are four takeaways: ...

The Trump administration is defending a Biden-era decision to reject drug manufacturer plans that would allow them to discount medicines through a rebate rather than up front under a federal drug ...

The Department of Health and Human Services said its decision to prevent drug companies from implementing a 340B rebate model “was within its statutory authority,” according to a department brief ...

The Trump administration defended HHS’ rejection of drugmakers' 340B rebate models “at this time,” but suggested that the ...

CareArc proudly announces that it has successfully passed the Health Resources & Services Administration (HRSA) Operational Site Visit (OSV) with no findings. This achievement underscores CareArc’s un ...

On March 5, 2025, the Center for Clinical Standards and Quality (CCSQ) within the Centers for Medicare & Medicaid Services (CMS) released a Quality ...

Four healthcare groups have filed an amicus brief in opposition to Johnson & Johnson's 340B rebate model, arguing the policy undermines federal law and threatens safety-net hospitals.